ArticleCureus2026
Use of Poloxamer 188 Dressing in the Treatment of Facial and Scalp Burns in Pediatric Patients: A Case Series.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo report the use of dressings with a surfactant component in the treatment of facial and scalp burns in pediatric patients and their progression in the epithelization process. METHODOLOGY: Retrospective observational study analyzing patients treated in our unit from September to December 2024. Pediatric patients with superficial and deep second-degree facial burns were included, and a Poloxamer 188-based dressing (PluroGel©; Medline Industries, Northfield, IL, US) was applied until complete epithelialization of the lesions.
resultsSeven pediatric patients with second-degree facial and/or scalp burns were treated with a Poloxamer 188-based dressing. The mean epithelialization time was 11.9 ± 3.3 days. Superficial burns healed faster (9.5 ± 4.9 days) than mixed-depth burns (12.8 ± 2.6 days). No adverse reactions or infections were observed. Verbal patients described the application as pleasant and reported reduced pruritus.
conclusionsThe use of a Poloxamer 188-based dressing in pediatric facial and scalp burns was well tolerated and associated with favorable healing in anatomically sensitive areas. Its thermoresponsive micellar properties support atraumatic wound management and timely epithelialization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.